CXCL10 and lepromatous leprosy: As a second biomarker for RR in multiple ethnic backgrounds, increased serum IP-10 levels were identified, whereas CCL18, which is elevated in lepromatous leprosy [30], decreased at early RR in 6/10 patients who developed RR.